Supplement: CRISPR Enters the Clinic
Using CRISPR-Altered Cells to Fight Disease
Supplement: CRISPR in the Courthouse
An Interview with Law Professor Jacob Sherkow
HPLC Summit Offers Expansive Biomolecular Views
High-Performance Liquid Chromatography (HPLC) Never Plateaus
Molecular Diagnostics Brings Patients Hope
NGS Advancements Pave the Way for New Drug-Resistance Research
For full access to this article login to GEN Select now.
Advertorial: Accelerating Therapeutic Development and Manufacturing
Using a Single High-Performance Delivery Platform for Cell Engineering
- Identify more relevant and efficacious candidates faster, more cost-effectively, and with reduced risk. These goals are common to researchers developing therapeutics of all modalities, whether small molecules, proteins and antibodies, or cell-based medicines. Flexible, efficient cell engineering is central to attaining these goals. MaxCyte’s delivery platform accelerates the discovery/development, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.